Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xad4
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 75M | $63M | -7% | Sep 2024 |
|
| Braidwell | 54M | $45M | -18% | Sep 2024 |
|
| D. E. Shaw & Co | 52M | $44M | 0% | Sep 2024 |
|
| Weiss Asset Management LP[1 | 47M | $38M | 78% | Jun 2024 |
|
| Aristeia Capital | 31M | $25M | 0% | Jun 2024 |
|
| MacKay Shields | 23M | $19M | 0% | Sep 2024 |
|
| Nuveen Asset Management | 22M | $18M | 20% | Jun 2024 |
|
| Laurion Capital Management | 19M | $16M | 0% | Sep 2024 |
|
| Advent Capital Management | 19M | $16M | -18% | Sep 2024 |
|
| CNH Partners | 18M | $15M | 0% | Sep 2024 |
|
| State Street Corporation | 14M | $12M | -13% | Jun 2024 |
|
| Sona Asset Management | 12M | $9.3M | 0% | Jun 2024 |
|
| Wells Fargo & Company | 11M | $8.9M | 0% | Sep 2024 |
|
| Bank of America Corporation | 11M | $8.7M | -41% | Sep 2024 |
|
| Calamos Advisors | 10M | $8.4M | 0% | Sep 2024 |
|
| Silverback Asset Management | 7.0M | $5.9B | -30% | Sep 2024 |
|
| BlackRock | 6.8M | $5.3M | 18% | Jun 2024 |
|
| BlackRock | 6.1M | $5.1M | 100% | Sep 2024 |
|
| Lazard Asset Management | 5.5M | $4.6M | 100% | Sep 2024 |
|
| SSI Investment Management | 4.5M | $3.8M | 0% | Sep 2024 |
|
| Jump Financial | 4.0M | $3.3M | 100% | Sep 2024 |
|
| New York State Common Retirement Fund | 2.9M | $2.5M | 0% | Sep 2024 |
|
| Bnp Paribas Investment Partners | 2.5M | $2.1M | 0% | Sep 2024 |
|
| Oaktree Capital Management | 2.4M | $2.0M | -33% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 2.1M | $1.7M | 0% | Sep 2024 |
|
| CSS | 1.7M | $1.5M | 67% | Sep 2024 |
|
| Palisade Capital Management | 1.5M | $1.2M | 0% | Jun 2024 |
|
| Jpmorgan Chase & Co | 1.3M | $1.1M | 125% | Sep 2024 |
|
| Russell Investments | 513k | $419k | -48% | Jun 2024 |
|
| Sunrise Partners Limited Partnership | 511k | $430k | -26% | Sep 2024 |
|
| HighTower Advisors | 250k | $200k | 100% | Jun 2024 |
|
| Sei Investments | 156k | $130k | 0% | Sep 2024 |
|
| Context Capital Management | 61k | $52M | 27% | Sep 2024 |
|
| SG Americas Securities | 22k | $1.8M | 0% | Sep 2024 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Jun 2024 | 18M | $15M |
| Aequim Alternative Investments | Jun 2024 | 7.5M | $6.0M |
| Morgan Stanley | Mar 2024 | 2.8M | $2.3M |
| Millennium Management | Jun 2024 | 2.5M | $2.0M |
| DeepCurrents Investment Group | Mar 2024 | 1.8M | $1.8M |
| Jane Street | Jun 2024 | 700k | $560k |
| Verition Fund Management | Mar 2024 | 554k | $454k |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | Jun 2024 | 450k | $363k |
| Rsm Us Wealth Management | Jun 2024 | 24k | $19k |